Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Collier

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
Pediatric Obesity|December 31, 2020
Associations between maternal obesity, gestational cytokine levels and child obesity in the NEST cohortRachel L Maguire, John S House, Dillon T Lloyd, et al.
Journal of Medicinal Chemistry|June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γPhilip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2014
Strategies for the modulation of phase II metabolism in a series of PKCε inhibitorsJeremy J Clemens, Timothy Coon, Brett B Busch, et al.
Journal of Medicinal Chemistry|July 2, 2016
Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical ProfilesJohn J Court, Carl Poisson, Andrzej Ardzinski, et al.
Journal of Medicinal Chemistry|May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)Jon H Come, Philip N Collier, James A Henderson, et al.
Journal of Medicinal Chemistry|December 6, 2021
Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1Michael J Boyd, Philip N Collier, Michael P Clark, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
Pediatric Obesity|December 31, 2020
Associations between maternal obesity, gestational cytokine levels and child obesity in the NEST cohortRachel L Maguire, John S House, Dillon T Lloyd, et al.
Journal of Medicinal Chemistry|June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γPhilip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2014
Strategies for the modulation of phase II metabolism in a series of PKCε inhibitorsJeremy J Clemens, Timothy Coon, Brett B Busch, et al.
Journal of Medicinal Chemistry|July 2, 2016
Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical ProfilesJohn J Court, Carl Poisson, Andrzej Ardzinski, et al.
Journal of Medicinal Chemistry|May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)Jon H Come, Philip N Collier, James A Henderson, et al.
Journal of Medicinal Chemistry|December 6, 2021
Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1Michael J Boyd, Philip N Collier, Michael P Clark, et al.
Pageof 10